Tag Archives | Biogen

Shareholder Democracy Network on Drugs

Shareholder Democracy Network on Drugs

Drugs are being priced out of reach. The new web platform, Shareholder Democracy, will enable millions of Americans to “vote” on pending 2019 shareholder resolutions at six pharmaceutical companies. Shareholder Democracy Network and its drug-pricing ballot for stakeholders will be launched during a phone-based news conference at 1 p.m. ET/10 a.m. PT on Tuesday (February […]

Continue Reading ·

Biogen (BIIB): Proxy Score 47 – Proxy Access Victory

Biogen Inc. (BIIB) discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. It is one of the stocks in my portfolio. Their annual meeting is coming up on 6/10/2015. ProxyDemocracy.org had the vote of five funds (removed 2nd Calvert from table below, since it was duplicative) when I checked and voted […]

Continue Reading ·

Proxy Access Win at Biogen & Other Efforts in 2015

My wife and I don’t have the resources to or stock holdings to allow us to file 75 proxy access shareholder proposals, like New York City Comptroller Scott Stringer’s Boardroom Accountability Project. However, I have been writing about proxy access for 20 years and, together with Les Greenberg, filed the petition in 2002 with the […]

Continue Reading ·
Biogen

Biogen Idec, $BIIB: Proxy Vote

Biogen Idec, $BIIB, is one of the stocks in my portfolio. Their annual meeting is June 12, 2014. ProxyDemocracy.org had collected the votes of four funds when I checked and voted on 6/10/2014. ProxyDemocracy.org now has collected the votes of five funds.  I voted with management 46% of the time.  View Proxy Statement. Read Warnings below. What follows are my recommendations on how to […]

Continue Reading ·

Powered by WordPress. Designed by WooThemes